Sign up to save your podcasts
Or
Share 16. Management of obesity with Philip Newland-Jones
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
16. Management of obesity with Philip Newland-Jones
Welcome to the latest episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. Today, your host Jonathan Underhill, Medicines Clinical Adviser at PrescQIPP, talks to Philip Newland-Jones about new treatments for obesity and the updated NICE guideline from January 2025.
Philip is a Consultant Pharmacist in Diabetes and Endocrinology and leads a large dynamic team at University Hospital Southampton. He works at a National level on various committees including being the lead pharmacist for the NHS England Diabetes and Endocrinology Clinical Reference Group.
Jonathan and Philip discuss various challenging and sometimes controversial issues around the management of obesity. The evidence for the effectiveness of some of the medicines options is impressive, but they are not without side effects - careful and appropriate use is key. Many new medicines are in development and Philip gives us an insight into what we can expect on the horizon.
PrescQIPP resources mentioned in this episode:
- Bulletin 323: Bariatric surgery July 2023
- PrescQIPP Prescribing Mastery; Prescribing Hot topics 26th March 2025
Useful NICE obesity resources:
- Tirzepatide: local formulary information
- A practical guide to using medicines to manage overweight and obesity
Other resources mentioned in this episode:
- NHS England Interim commissioning guidance for
tirzepatide (Mounjaro®)
A new episode of Talking Meds will be available every other Friday.
If you have feedback or suggestions for future topics and guests please submit them to [email protected]
PrescQIPP is funded by the NHS for the NHS, and our aim is to improve medicines-related care for patients. We do this by producing high quality evidence-based resources and training, and by facilitating networks between NHS organisations and professionals.
The majority of pharmacists and other healthcare professionals across the UK can access our resources by registering and logging on to our website. If you have any difficulty accessing the website you can email [email protected] and we’ll aim to sort things out for you.
Find out more about PrescQIPP here
View all episodes
By PrescQIPP C.I.C.Welcome to the latest episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. Today, your host Jonathan Underhill, Medicines Clinical Adviser at PrescQIPP, talks to Philip Newland-Jones about new treatments for obesity and the updated NICE guideline from January 2025.
Philip is a Consultant Pharmacist in Diabetes and Endocrinology and leads a large dynamic team at University Hospital Southampton. He works at a National level on various committees including being the lead pharmacist for the NHS England Diabetes and Endocrinology Clinical Reference Group.
Jonathan and Philip discuss various challenging and sometimes controversial issues around the management of obesity. The evidence for the effectiveness of some of the medicines options is impressive, but they are not without side effects - careful and appropriate use is key. Many new medicines are in development and Philip gives us an insight into what we can expect on the horizon.
PrescQIPP resources mentioned in this episode:
- Bulletin 323: Bariatric surgery July 2023
- PrescQIPP Prescribing Mastery; Prescribing Hot topics 26th March 2025
Useful NICE obesity resources:
- Tirzepatide: local formulary information
- A practical guide to using medicines to manage overweight and obesity
Other resources mentioned in this episode:
- NHS England Interim commissioning guidance for
tirzepatide (Mounjaro®)
A new episode of Talking Meds will be available every other Friday.
If you have feedback or suggestions for future topics and guests please submit them to [email protected]
PrescQIPP is funded by the NHS for the NHS, and our aim is to improve medicines-related care for patients. We do this by producing high quality evidence-based resources and training, and by facilitating networks between NHS organisations and professionals.
The majority of pharmacists and other healthcare professionals across the UK can access our resources by registering and logging on to our website. If you have any difficulty accessing the website you can email [email protected] and we’ll aim to sort things out for you.
Find out more about PrescQIPP here